The Current Controversies in the Treatment of Ischemic Nephropathy and Prospection in the Application of Mesenchymal Stem Cells

Qin-min GE,Shu-ming PAN,Xiang-yang ZHU

DOI: https://doi.org/10.3969/j.issn.1002-3429.2014.03.027

2014-01-01

Abstract:Ischemic kidney diseases,acute or chronic,are common clinical entities with high mortality and morbidity that increase the risk for cardiovascular diseases. The pathophysiology of ischemic kidney disease is multifaceted,involves complex hormonal-immunological-cell interactions,and leads to damage in multiple cell types,which is often resistant to conventional therapy. In recent years,multi-center clinical trials prove that endovascular stent has no significant benefit to blood pressure,renal function,and disease prognosis of atherosclerotic renal artery stenosis. Thus,novel strategies are needed to repair the renal parenchyma and preserve kidney function. Mesenchymal stem cells( MSC) confer renal protection through paracrine / endocrine effects and to some degree possibly by direct engraftment. Their anti-inflammatory and immune-modulatory properties target multiple cascades in the mechanisms of ischemic kidney disease. This review focuses on the recent progress on the use of MSC to prevent kidney injury in both the acute and chronic forms of ischemic kidney injury.